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Neuropathic pain after femoropopliteal bypass
surgery
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Objective: This retrospective study was performed to investigate prolonged postoperative pain in the area of the proximal
or distal scar or the bypass tunnel after femoropopliteal bypass surgery to treat symptomatic peripheral arterial disease.
Patients and Methods: Ninety-three patients with peripheral arterial disease who underwent femoropopliteal bypass
surgery between January 2000 and December 2002 were included in the study. The short-form McGill Pain Question-
naire was used to score pain. Ultrasound examination of the soft tissue around the graft was performed to exclude other
pathologic conditions responsible for pain, such as inflammatory processes, perigraft reactions, swollen lymph nodes, and
hematomas.
Results: Pain in at least one scar existed in 22 patients on average 13.9  9.8 months after surgery. In 10 patients pain
existed simultaneously along the inguinal scar and the above-knee or below-knee scar. Pain along the bypass tunnel was
experienced by seven patients. Most patients had mild to moderate pain. The mean numeric ranking score of pain severity
in patients with pain was 4.2 2.3. The occurrence of prolonged postoperative pain was not associated with age, gender,
diabetes, indication for surgery, material or type of bypass, number of preceding operations, or postoperative wound
complications. Only follow-up time after femoropopliteal bypass surgery tended to be lower in patients with pain
compared with those without pain.
Conclusion: Prolonged postoperative neuropathic pain along the distal and proximal incision or the bypass tunnel exists
in one fourth of patients after femoropopliteal bypass surgery. Patients should be informed of this kind of complication
before surgery. The results of our study justify further investigations of the origin and treatment of this pain, to find
effective methods to reduce the incidence of prolonged postoperative pain after femoropopliteal bypass surgery. (J Vasc
Surg 2004;39:1284-7.)Longitudinal groin incision is a standard approach used
to expose the common femoral artery and the superficial
and deep femoral arteries for femoropopliteal bypass sur-
gery. Depending on where the distal anastomosis is
planned, the distal exposure is carried out with a longitu-
dinal incision from the medial femoral condyle running
dorsal to the proximal tibia or upward to a point overlying
the adductor magnus tendon.
Chronic postoperative scar pain, usually mild or mod-
erate, occurs in approximately 50% of patients after thora-
cotomy. However, in 5% of patients the pain is severe and
disabling.1,2 Groin or inguinal pain has been reported in
53.6% of patients 2 years after surgical hernia repair.3
Prolonged postoperative pain along the proximal or
distal scar or along the bypass tunnel has been observed at
our center after femoropopliteal bypass surgery, but, of
interest, to date nothing has been published on this topic.
To verify this finding, we investigated the proportion of
postoperative pain in the area of the proximal and distal scar
or the bypass tunnel in patients with symptomatic periph-
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PATIENTS AND METHODS
Patient selection and follow-up. To study a patient
population as homologous as possible, we decided a priori
to include only patients with standardized femoropopliteal
bypass surgery with just two scars and no pain before the
bypass procedure, who were operated on between January
2000 and December 2002. Patients with vein grafts or
composite grafts were included only when the vein was
harvested from the contralateral limb. A further inclusion
criterion was that bypass surgery was the final intervention
carried out in the evaluated limb. A detailed baseline eval-
uation of patient status was performed. During this inter-
view we confirmed that the evaluated pain was not present
before femoropopliteal bypass surgery. Patients with pain
of origin other than bypass surgery were not included in the
study. In all patients the surgical procedure was carried out
at least 3 months before inclusion in the present study, to
exclude acute wound pain as the source of pain. In cases of
repeat procedures, we included patients only if the surgical
approach was always carried out at the preexisting scar.
During the inclusion period 251 patients underwent fem-
oropopliteal bypass surgery. However, according to the
study criteria 158 patients were not eligible for inclusion in
the study. Finally, 93 patients were included in the study
group. In all cases, standard technique for femoropopliteal
bypass surgery was used, as described.4
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were familiarized with the standard pain questionnaire.
This questionnaire referred to a German version of the
short-form McGill Pain Questionnaire.5 The questionnaire
contained the numeric pain scale of pain severity to score
the intensity of pain, and 11 descriptors representing the
sensory dimension of pain experience and four descriptors
representing the affective dimension. Each descriptor was
ranked on an intensity scale of 0 to 3, where 0 none, 1
mild, 2  moderate, and 3  severe. In addition, all
patients with pain were asked about frequency of analgesic
consumption in association with bypass surgery.
Ultrasound examination was performed by an experi-
enced radiologist using an HDI 5000 (Philips Medical
Systems, Bothell, Wash) and a broadband linear array trans-
ducer working at 5 to 12 MHz. High-resolution com-
pound imaging was used in all examinations. The soft tissue
around the anastomosis of the bypass was assessed with the
help of gray-scale ultrasound. We looked for fluid around
the graft, pseudoaneurysm, swollen lymph nodes, hema-
toma, and neuroma. Second, color Doppler ultrasound was
performed to detect narrowing or occlusion of the bypass,
anastomosis stenosis, fistulas, or inflammatory processes, or
to confirm a pseudoaneurysm detected in gray-scale mode.
Physicial examination was carried out to exclude other
causes of pain around the scar, such as claudication, nerve
root or spinal cord compression, and osteoarthritis of the
hip.
Definitions. An inguinal scar results from a longitu-
dinal groin incision over the common femoral artery. The
incision is placed with at least one third of its length above
the inguinal crease. An above-knee scar results from a lon-
gitudinal incision made 1 cm behind the medial femoral
condyle to a point overlying the adductor magnus tendon.
A below-knee scar results from a longitudinal incision that
starts 1 cm behind the medial condyle and runs distally
behind the medial border of the tibia. The bypass tunnel
lies beneath the sartorius muscle and superficial to the
adductor magnus muscle, and the femoropopliteal bypass
runs through it.
Statistical analysis. Statistical analysis was performed
with the Statistical Package for Social Sciences for Win-
dows, version 10.1.3 (SPSS, Chicago, Ill). Continuous
variables were normally distributed (tested with the Kol-
mogorov-Smirnov test), and were compared between pa-
tients with and without pain with unpaired t tests. These
data are given as mean and SD. Categorial variables were
compared with the Pearson 2 test or the Fisher exact test,
where appropriate. Variables contributing to pain were also
identified with stepwise logistic regression analysis. Only
variables with a value of P  .3 at univariate analysis were
included in the regression model.
RESULTS
A total of 93 patients who had undergone bypass
surgery were included in the study. In patients with two
affected limbs, one limb was randomly assigned for further
statistical analysis of the data. The indications for femoro-popliteal bypass surgery were intermittent claudication in
53 patients (57%) and critical limb ischemia in 40 patients
(43%). Patient mean age was 68.0  11.2 years. Baseline
characteristics regarding surgical technique and material
are given in Table I. In all patients femoropopliteal bypass
surgery was the latest surgical procedure conducted in the
affected limb. Fourteen patients (15.1%) were treated sur-
gically or endoluminally at least once, 13.7  10 months
before the femoropopliteal bypass procedure (Table I).
After these interventions, exploration of the groin was
performed in 17 patients (18.3%) and exploration of the
knee region was performed in 12 patients (12.9%) at least
once before the final femoropopliteal bypass surgery (Table
I). Wound complications, located in the inguinal region,
occurred in seven treated patients (7.5%), and included
wound infection (n  2), bleeding (n  3), and lymphatic
fistula (n  2).
Mean follow-up time was 17.6  10.1 months. Scar
pain in at least one area was observed in 22 patients
(23.4%), and continued for a mean of 13.9  9.8 months
after surgery (Table II). In 10 patients (10.8%) pain existed
simultaneously along the inguinal scar and the above-knee
or below-knee scar, for a mean duration of 13.0  9.1
months. Pain along the bypass tunnel was experienced by
Table I. Baseline characteristics of study population,
femoropopliteal bypass type and material, and frequency
and type of surgical and interventional procedures before
femoropopliteal bypass surgery
Characteristic n %
Age (y) 68  11.2
Gender
Female 32 34.4
Male 61 65.6
Follow-up (mo) 17.6  10.1
Type of femoropopliteal bypass
Above-knee 61 65.5
Below knee 32 34.4
Bypass material
ePTFE 69 74.2
Reversed vein 20 21.5
Composite graft (ePTFE
plus vein)
4 4.3
Number of previous surgical or
interventional procedures on
limb
1 14 15.1
2 5 5.4
3 4 4.3
Number of explorations per
limb in inguinal region
0 72 77.4
1 17 18.3
2 3 3.2
2 1 1.1
Number of explorations per
limb in knee region
0 78 83.9
1 12 12.9
2 3 3.2
ePTFE, Expandable polytetrafluoroethylene.
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region never existed alone, but was always coupled with
scar pain (Table II).
Patients reported the pain as stabbing, burning, and
aching (Table III). Results of the numeric pain scale of pain
severity are given in Table IV. Pain existed either as contin-
uous pain in six patients (27.7%) or as pain attacks in 16
patients (72.3%). Sleep disturbances were reported by two
patients. Factors that aggravated pain were changes in the
weather, cold, exercise, and rest. Nonsteroidal anti-inflam-
matory drugs were taken by five patients on a regular basis.
Of these patients, none had taken analgesic agents fre-
quently before the femoropopliteal bypass procedure.
None of the patients received opioid agents.
Ultrasound examination of patients with pain showed
no pathologic findings in the soft tissue around the bypass,
in particular, no fluid around the graft or an inflammatory
process. There were no swollen lymph nodes, tumors, or
hematoma. In two patients an aneurysm of the proximal
anastomosis developed. In two other patients the bypass
was occluded.
When we compared patients with and without pain, we
observed no differences between the two groups with re-
gard to gender, age, diabetes mellitus, indication for sur-
gery, material and type of bypass, postoperative occurrence
of wound complications, number of preceding operations,
and number of preceding explorations of the inguinal re-
gion and of the knee region (Table V). Only follow-up time
since femoropopliteal bypass surgery showed borderline
significance between patients with and without pain (13.9
 9.8 months vs 18.7 10.0 months; P .051). A logistic
regression model showed similar results: none of the men-
tioned variables predicted pain with the exception of a
borderline significance for follow-up time (P  .055).
Table II. Frequency of pain localization and mean and
standard deviation of pain time in months
Pain
localization n % Pain months
Inguinal scar 15 16.1 13.2  10.1
Above-knee scar 4 4.3 15.8  12.3
Below-knee scar 3 3.2 15.1  6.6
Bypass tunnel 7 7.5 12.7  8.7
Table III. Sensory dimension of pain experience ranked
on intensity scale
Sensory
dimension
Intensity scale
Mild Moderate Severe
n % n % n %
Stabbing 5 22.7 4 18.2 2 9.1
Hot, burning 2 9.1 1 4.5 1 4.5
Aching 4 18.2 3 13.6 0 —
Numbers provide absolute and relative frequency of patients in relation to
sensory dimension and intensity score of pain based on total of 22 patients.DISCUSSION
In the present study, 22 of 93 patients (23.7%) had
prolonged pain along the scar or along the bypass tunnel
after femoropopliteal bypass surgery. Mild to moderate
pain predominated. Thus the incidence of prolonged pain
after femoropopliteal bypass surgery is less than the inci-
dence reported for chronic pain after posterolateral thora-
cotomy or surgical hernia repair. Incidence of 50% or more
is estimated for these latter procedures.1-3,6
Pain experienced by patients in the present study was
related to the broad descriptive category of neuropathic
pain, that is, based on a dysfunction of the neuronal sys-
tem.7,8 Because of the many etiologic manifestations of
neuropathic pain, different types can be categorized, ac-
cording to site of initial injury of the nerve.9 This includes
injury to the nociceptive system, which occurs during a
surgical procedure. According to this differentiation, scar
pain after femoropopliteal bypass surgery should be cate-
gorized as a postsurgical syndrome.9
After traumatic injury to the nociceptive system, pain
may continue or even increase once tissue healing is com-
plete.10 Indeed, in the present study all patients with pain
had well-healed scars, and ultrasound examination showed
no pathologic conditions. Pain was localized to the scar in
all patients, and was not referable to a single nerve distri-
bution. In 7.5% of patients pain around the scars was
combined with pain localized along the medial region of
the thigh in accordance with the run of the bypass tunnel.
In all patients the surgical procedure was carried out at
least 3 months before inclusion in the study. The duration
of pain ranged between 3.4 and 32.2 months, meaning that
pain around the scar and along the bypass tunnel after
femoropopliteal bypass surgery tends to become chronic.
In accordance with chronic post-thoracotomy pain, which
is defined by the International Association for the Study of
Pain as “pain that recurs or persists along a thoracotomy
incision at least 2 months following the surgical proce-
dure,”11 scar pain after femoropopliteal bypass surgery can
be classified as chronic pain. The only difference between
patients with and without pain was a shorter follow-up time
for patients with pain. One explanation might be that the
group without pain at the time of interview also included
patients who had experienced periods of prolonged pain
that resolved in the meanwhile. This raises some hope that
in some of the patients in the current pain group the
prolonged pain will resolve over the ongoing observation
period.
One basic characteristic of femoropopliteal bypass sur-
gery is that two incisions, one proximal and one distal, need
to be performed. Indeed, in 10.8% of patients, postopera-
tive prolonged pain was localized to both the inguinal and
the knee regions.
The main findings of the present study document
clearly that prolonged postoperative pain along the distal
and proximal incision or the bypass tunnel exists in about
one fourth of patients who undergo femoropopliteal bypass
surgery to treat peripheral arterial disease. In view of the
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with femoropopliteal bypass surgery, and consequently in
conjunction with medicolegal issues, patients should be
informed about this type of complication before surgery. In
the present study, 18.5% of patients with pain took analge-
sic agents frequently. Insufficient relief with analgesic ther-
apy was subjectively reported in all cases. This underlines
the demand for an adequate therapy. A wide variety of
medications are used in the treatment of neuropathic pain,
reflecting the lack of any one highly effective regimen.
Properly randomized, double-blind, placebo-controlled
studies are largely lacking.8 In general, anticonvulsant
Table IV. Intensity of pain scored by NRS* based on a tot
NRS 0 1 2 3 4
No. of patients 71 0 5 5 3
Percent 76.3 0 5.4 5.4 3.2
No pain
NRS, Numerical rating scale.
*0, No pain; 10, excruciating pain.
Table V. Comparison between patients with and without
pain
Patients
without pain
(n  71)
Patients
with pain
(n  22)
n % n %
Age (y) 67.8  11.8 69.6  9.2
Gender
Female 25 35.2 7 31.8
Male 46 64.8 15 68.2
Follow-up (mo) 18.7  10.0 13.9  9.8*
Bypass type
Femoro–above knee 48 67.6 13 59.1
Femoro-infrapopliteal 23 32.4 9 40.9
Bypass material
Prosthesis 52 73.2 17 77.3
Vein 15 21.1 5 22.7
Composite 4 5.6 0
Explorations of knee
0 59 83.1 19 86.4
1 10 14.1 2 9.1
2 2 2.8 1 4.5
Explorations of groin
0 56 78.9 16 72.7
1 13 18.3 4 18.2
2 2 2.8 2 9.1
Complications
Yes 5 2
No 66 20
Diabetes mellitus 23 32.4 4 18.2
*P  .051 for comparison with patients without pain.agents such as carbamazepine, phenytoin, and gabapentinhave demonstrated analgesic efficacy in painful neuropathic
conditions.12-14
Inasmuch as this is the first systematic evaluation of
prolonged postoperative pain after femoropopliteal bypass
surgery, with a limited and selected study population, the
findings must be kept in perspective. Nevertheless, the
results of our study justify further investigations regarding
the origin and treatment of this pain in a larger study
population, to find effective methods to reduce the inci-
dence of prolonged postoperative pain after femoropopli-
teal bypass surgery.
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